Differences in gut bacteria composition in people with myasthenia gravis (MG) may be a promising avenue to explore in…
Marisa Wexler, MS
senior science writer
Marisa Horak joined Bionews in 2018 right after she completed her master’s degree in cellular and molecular pathology. She has dedicated her career to making scientific and medical information more accessible to people affected by rare and chronic disorders.
Education
- MS, Cellular and Molecular Pathology, University of Pittsburgh
- BS, Microbiology, Michigan State University
Professional Accomplishments
- Universal concept signature analysis: genome-wide quantification of new biological and pathological functions of genes and pathways, 2019, Briefings in Bioinformatics
- Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity, 2018, Oncotarget
- Insights on processes of evolutionary tumor growth, 2016, Atlas Genet Cytogenet Oncol Haematol
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
An inflammation-associated protein called calprotectin is present at abnormally high levels in the blood of people with myasthenia gravis…
Myasthenia gravis (MG) tends to be more severe in people who are female, obese, or who took a long…
Immunovant will use a $200 million strategic investment from Roivant Sciences to advance IMVT-1401, its investigational therapy for…
A very rare case of a myasthenia gravis (MG) crisis caused by the Moderna COVID-19 vaccine was described recently…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
Following a review of available clinical data, Immunovant has announced plans to resume clinical testing of the investigational medication…
People with myasthenia gravis (MG) who have difficulty swallowing are more likely to have poor clinical outcomes, according to…
Editor’s note: The Myasthenia Gravis News team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April…
When used over long periods of time, Soliris (eculizumab) does not increase the risk of infections in people with…